S, R., R, K., R, S., & S, C. (2025). Advancements in neuroblastoma treatment: FDA-approved drugs and role of phytochemicals. Molecular biology reports, 52(1), 516. https://doi.org/10.1007/s11033-025-10633-w
Chicago Style (17th ed.) CitationS, Rajpoot, Kumar R, Singh R, and Chandel S. "Advancements in Neuroblastoma Treatment: FDA-approved Drugs and Role of Phytochemicals." Molecular Biology Reports 52, no. 1 (2025): 516. https://doi.org/10.1007/s11033-025-10633-w.
MLA (9th ed.) CitationS, Rajpoot, et al. "Advancements in Neuroblastoma Treatment: FDA-approved Drugs and Role of Phytochemicals." Molecular Biology Reports, vol. 52, no. 1, 2025, p. 516, https://doi.org/10.1007/s11033-025-10633-w.
Warning: These citations may not always be 100% accurate.